(Q38302571)

1 September 2017

title

Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. (English)

1 reference

1 September 2017

4

Lindahl U

1 reference

1 September 2017

Loo BM

1

1 reference

1 September 2017

Kreuger J

series ordinal

2

1 reference

1 September 2017

Jalkanen M

series ordinal

3

1 reference

1 September 2017

Salmivirta M

series ordinal

5

1 reference

1 September 2017

language of work or name

English

0 references

publication date

21 February 2001

1 reference

Journal of Biological Chemistry

1 September 2017

published in

1 reference

1 September 2017

volume

276

1 reference

1 September 2017

issue

20

1 reference

1 September 2017

page(s)

16868-16876

1 reference

The heparin-binding (fibroblast) growth factor family of proteins

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

The coordinated regulation of heparan sulfate, syndecans and cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Proteoglycans: structures and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Heparan sulfates mediate the binding of basic fibroblast growth factor to a specific receptor on neural precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Production and characterization of the extracellular domain of recombinant human fibroblast growth factor receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Defining the interleukin-8-binding domain of heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Mode of interaction between platelet factor 4 and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Formation of anhydrosugars in the chemical depolymerization of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Identification of oversulphated galactosaminoglycans in intestinal-mucosal mast cells of rats infected with the nematode worm Nippostrongylus brasiliensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Sequence analysis of heparan sulphate and heparin oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

A strategy for rapid sequencing of heparan sulfate and heparin saccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Copper and calcium binding motifs in the extracellular domains of fibroblast growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Nature of the interaction of heparin with acidic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Structural basis for FGF receptor dimerization and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Structural diversity of N-sulfated heparan sulfate domains: distinct modes of glucuronyl C5 epimerization, iduronic acid 2-O-sulfation, and glucosamine 6-O-sulfation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

Heparan Sulfate Proteoglycan Modulates Keratinocyte Growth Factor Signaling through Interaction with both Ligand and Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M011226200

21 January 2018

Identifiers

DOI

10.1074/JBC.M011226200

1 reference

1 September 2017

1 reference